| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |